| Product Code: ETC10688948 | Publication Date: Apr 2025 | Updated Date: Sep 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Bhawna Singh | No. of Pages: 65 | No. of Figures: 34 | No. of Tables: 19 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Vietnam Oncology Biosimilars Market Overview |
3.1 Vietnam Country Macro Economic Indicators |
3.2 Vietnam Oncology Biosimilars Market Revenues & Volume, 2021 & 2031F |
3.3 Vietnam Oncology Biosimilars Market - Industry Life Cycle |
3.4 Vietnam Oncology Biosimilars Market - Porter's Five Forces |
3.5 Vietnam Oncology Biosimilars Market Revenues & Volume Share, By Drug Type, 2021 & 2031F |
3.6 Vietnam Oncology Biosimilars Market Revenues & Volume Share, By Application, 2021 & 2031F |
3.7 Vietnam Oncology Biosimilars Market Revenues & Volume Share, By Distribution Channel, 2021 & 2031F |
3.8 Vietnam Oncology Biosimilars Market Revenues & Volume Share, By End User, 2021 & 2031F |
4 Vietnam Oncology Biosimilars Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of cancer in Vietnam |
4.2.2 Government initiatives to promote biosimilars usage |
4.2.3 Rising healthcare expenditure and infrastructure development |
4.3 Market Restraints |
4.3.1 Limited awareness and acceptance of biosimilars among healthcare professionals and patients |
4.3.2 Regulatory challenges and intellectual property rights issues |
5 Vietnam Oncology Biosimilars Market Trends |
6 Vietnam Oncology Biosimilars Market, By Types |
6.1 Vietnam Oncology Biosimilars Market, By Drug Type |
6.1.1 Overview and Analysis |
6.1.2 Vietnam Oncology Biosimilars Market Revenues & Volume, By Drug Type, 2021 - 2031F |
6.1.3 Vietnam Oncology Biosimilars Market Revenues & Volume, By Monoclonal Antibodies, 2021 - 2031F |
6.1.4 Vietnam Oncology Biosimilars Market Revenues & Volume, By Immunomodulators, 2021 - 2031F |
6.1.5 Vietnam Oncology Biosimilars Market Revenues & Volume, By Erythropoietins, 2021 - 2031F |
6.1.6 Vietnam Oncology Biosimilars Market Revenues & Volume, By G-CSF (Granulocyte Colony-Stimulating Factors), 2021 - 2031F |
6.2 Vietnam Oncology Biosimilars Market, By Application |
6.2.1 Overview and Analysis |
6.2.2 Vietnam Oncology Biosimilars Market Revenues & Volume, By Breast Cancer, 2021 - 2031F |
6.2.3 Vietnam Oncology Biosimilars Market Revenues & Volume, By Lung Cancer, 2021 - 2031F |
6.2.4 Vietnam Oncology Biosimilars Market Revenues & Volume, By Colorectal Cancer, 2021 - 2031F |
6.2.5 Vietnam Oncology Biosimilars Market Revenues & Volume, By Blood Cancer, 2021 - 2031F |
6.3 Vietnam Oncology Biosimilars Market, By Distribution Channel |
6.3.1 Overview and Analysis |
6.3.2 Vietnam Oncology Biosimilars Market Revenues & Volume, By Hospital Pharmacies, 2021 - 2031F |
6.3.3 Vietnam Oncology Biosimilars Market Revenues & Volume, By Retail Pharmacies, 2021 - 2031F |
6.3.4 Vietnam Oncology Biosimilars Market Revenues & Volume, By Online Pharmacies, 2021 - 2031F |
6.3.5 Vietnam Oncology Biosimilars Market Revenues & Volume, By Specialty Pharmacies, 2021 - 2031F |
6.4 Vietnam Oncology Biosimilars Market, By End User |
6.4.1 Overview and Analysis |
6.4.2 Vietnam Oncology Biosimilars Market Revenues & Volume, By Hospitals, 2021 - 2031F |
6.4.3 Vietnam Oncology Biosimilars Market Revenues & Volume, By Clinics, 2021 - 2031F |
6.4.4 Vietnam Oncology Biosimilars Market Revenues & Volume, By Diagnostic Centers, 2021 - 2031F |
6.4.5 Vietnam Oncology Biosimilars Market Revenues & Volume, By Cancer Research Institutes, 2021 - 2031F |
7 Vietnam Oncology Biosimilars Market Import-Export Trade Statistics |
7.1 Vietnam Oncology Biosimilars Market Export to Major Countries |
7.2 Vietnam Oncology Biosimilars Market Imports from Major Countries |
8 Vietnam Oncology Biosimilars Market Key Performance Indicators |
8.1 Number of oncology biosimilars approved for use in Vietnam |
8.2 Rate of adoption of biosimilars in oncology treatments |
8.3 Investment in research and development of oncology biosimilars |
8.4 Patient satisfaction and outcomes with biosimilars treatment |
8.5 Number of partnerships and collaborations in the oncology biosimilars market |
9 Vietnam Oncology Biosimilars Market - Opportunity Assessment |
9.1 Vietnam Oncology Biosimilars Market Opportunity Assessment, By Drug Type, 2021 & 2031F |
9.2 Vietnam Oncology Biosimilars Market Opportunity Assessment, By Application, 2021 & 2031F |
9.3 Vietnam Oncology Biosimilars Market Opportunity Assessment, By Distribution Channel, 2021 & 2031F |
9.4 Vietnam Oncology Biosimilars Market Opportunity Assessment, By End User, 2021 & 2031F |
10 Vietnam Oncology Biosimilars Market - Competitive Landscape |
10.1 Vietnam Oncology Biosimilars Market Revenue Share, By Companies, 2024 |
10.2 Vietnam Oncology Biosimilars Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here